A safety and feasibility study of cell therapy in dilated cardiomyopathy

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 10, 2010, Pages 989-995

  Martino, H F ^a   Oliveira, P S ^a   Souza, F C ^a   Costa, P C ^a   Assuncao e Silva E ^a   Villela, R ^a   Gaze, M ^a   Weitzel, L H ^a   Oliveira, A ^b   Muccillo, F B ^a   Arvelo, S N S ^a   Sa R ^a   Guimaraes T C F ^a   Tura, B R ^a   Campos de Carvalho, A C ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

^b HOSPITAL PRÓ CARDÍACO   (Brazil)

Author keywords

Autologous transplantation; Bone marrow cells; Dilated cardiomyopathy; Ejection fraction; Mononuclear fraction; Treadmill test

Indexed keywords

AMIODARONE;

ADULT; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CARDIOGENIC SHOCK; CARDIOPULMONARY EXERCISE TEST; CELL THERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; LUNG EDEMA; MALE; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATIENT SAFETY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; WALKING;

EID: 78149261522     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500093     Document Type: Article

References (36)

1. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult (frst of two parts). N Engl J Med 1982; 307: 1051-1058.
2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary defnitions and classifcation of the cardiomyopathies: an American Heart Association Scientifc Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
3. Miller LW, Missov ED. Epidemiology of heart failure. Cardiol Clin 2001; 19: 547-555.
4. Chen M, Fan ZC, Liu XJ, Deng JL, Zhang L, Rao L, et al. Effects of autologous stem cell transplantation on ventricular electrophysiology in doxorubicin-induced heart failure. Cell Biol Int 2006; 30: 576-582.
5. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001; 37: 1726-1732.
6. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miya-hara Y, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardio-myopathy. Circulation 2005; 112: 1128-1135.
7. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-705.
8. Soares MB, Lima RS, Rocha LL, Takyia CM, Pontes-de-Car-valho L, de Carvalho AC, et al. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 2004; 164: 441-447.
9. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, et al. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009; 37: 1197-1205.
10. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hor-nung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-997.
11. Bartunek J, Dimmeler S, Drexler H, Fernandez-Aviles F,Galinanes M, Janssens S, et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J 2006; 27: 1338-1340.
12. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925-936.
13. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50: 1761-1767.
14. Patel AN, Sherman W. Cardiac stem cell therapy: advances from 2008. Cell Transplant 2009; 18: 243-244.
15. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294-2302.
16. Silva SA, Sousa AL, Haddad AF, Azevedo JC, Soares VE, Peixoto CM, et al. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. Cell Transplant 2009; 18: 343-352.
17. van Laake LW, Hassink R, Doevendans PA, Mummery C. Heart repair and stem cells. J Physiol 2006; 577: 467-478.
18. Arguero R, Careaga-Reyna G, Castano-Guerra R, Garrido-Garduno MH, Magana-Serrano JA, de Jesus Nambo-Lucio. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report. Arch Med Res 2006; 37: 1010-1014.
19. Seth S, Narang R, Bhargava B, Ray R, Mohanty S, Gulati G, et al. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathologi-cal results: the frst-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006; 48: 2350-2351.
20. Widimsky P, Penicka M. Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopa-thy. Int J Cardiol 2006; 111: 178-179.
21. Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leist-ner D, Fichtlscherer S, et al. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: fnal 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopa-thy. Circ Heart Fail 2009; 2: 417-423.
22. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by fow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213-226.
23. Foundation for Statistical Computing VA. Development Core Team. R: A language and environment for statistical computing. http://www.R-project.org.
24. Vilas-Boas F, Feitosa GS, Soares MB, Mota A, Pinho-Filho JA, Almeida AJ, et al. [Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease]. Arq Bras Cardiol 2006; 87: 159-166.
25. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987; 316: 1429-1435.
26. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
27. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autolo-gous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-1918.
28. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-121.
29. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Ham-brecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
30. Wollert KC, Meyer G P, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
31. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-1209.
32. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005; 85: 1373-1416.
33. Balsam LB, Wagers AJ, Christensen JL, Kofdis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668-673.
34. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not trans-differentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668.
35. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, He-scheler J, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10: 494-501.
36. Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 2007; 104: 17783-17788.